Artificial intelligence / news brief
Isomorphic Labs Raises $5 Billion for AI Drug Design
- Event
- Published

Isomorphic Labs raised a $5 billion Series C led by Greenoaks and Sequoia, with participation from Andreessen Horowitz, Alphabet and existing investors. The company says the capital will expand its IsoDDE drug-design engine and move candidates toward clinical trials. Its valuation was not disclosed, and its reported preclinical progress has not yet produced an approved medicine.
Why it matters
The unusually large round gives Alphabet's AI drug-design company substantial capital to bridge model development and clinical testing, where evidence remains pending.
Sources
- Isomorphic Labs announces Series C investment round (external site)Isomorphic Labs · primary source ·
- Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design (external site)The Next Web · coverage ·
- Sequoia, Greenoaks Lead Isomorphic Lab $5 Billion Funding Round (external site)Bloomberg News · coverage ·